Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Peter G. McLean"'
Autor:
Peter G. McLean, Andrew R. Calver, David H. Alpers, Stephen M. Collins, Fergus Shanahan, Kevin Lee
Publikováno v:
Gastroenterology Insights, Vol 1, Iss 1, Pp e3-e3 (2009)
The gastrointestinal tract and its associated mucosal immune system have been extensively studied in the context of their involvement in disease processes, both within the tract itself and in its associated organs. However, historically a number of a
Externí odkaz:
https://doaj.org/article/064465900deb47b78ab823426c69e654
Autor:
Peter G. McLean, S Christodoulides, Peter I. Duncan, Eirini Dimidi, Gabriela Bergonzelli, Kevin Whelan, Rafael Crabbe, Nashmil Emami, Shiva Taheri, C. Antonio De Castro, S. Mark Scott, Ausra Zdanaviciene, Petra Louis
Publikováno v:
Dimidi, E, Zdanaviciene, A, Christodoulides, S, Taheri, S, Louis, P, Duncan, P I, Emami, N, Crabbé, R, De Castro, C A, Mclean, P, Bergonzelli, G E, Whelan, K & Mark Scott, S 2019, ' Randomised clinical trial : Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation ', Alimentary Pharmacology & Therapeutics, vol. 49, no. 3 . https://doi.org/10.1111/apt.15073
BackgroundConstipation is a prevalent gastrointestinal disorder. Patient dissatisfaction with prescribed medications is common, and there is need for alternative management strategies. Evidence shows that Bifidobacterium species may be beneficial in
Autor:
Josh D. Neufeld, Marc Pigrau Pastor, Michael G. Surette, Pedro M. Miranda, Maria Ines Pinto-Sanchez, Michael D. Lynch, Philip Britz-McKibbin, Vivek Philip, Jun Lu, Jennifer Jury, Moreno-Gabriel Hagelsieb, Sacha Sidani, Premysl Bercik, Yikang Deng, Giada De Palma, Stephen M. Collins, Genevieve Umeh, Peter G. McLean, Gabriela Bergonzelli, Vi T Dang, Elena F. Verdu
Publikováno v:
Science Translational Medicine. 9
Irritable bowel syndrome (IBS) is a common disorder characterized by altered gut function and often is accompanied by comorbid anxiety. Although changes in the gut microbiota have been documented, their relevance to the clinical expression of IBS is
Autor:
A. Khoshdel, Premysl Bercik, Yikang Deng, Peter G. McLean, Jan D. Huizinga, Deborah Moine, David A. Sinclair, Bernard Berger, Xianxi Huang, Margaret Fahnestock, Jun Lu, Amber J. Park, Stephen M. Collins, Wolfgang Kunze, Elena F. Verdu, Patricia Blennerhassett, Gabriela Bergonzelli
Publikováno v:
Neurogastroenterology & Motility. 23:1132-1139
The probiotic Bifidobacterium longum NCC3001 normalizes anxiety-like behavior and hippocampal brain derived neurotrophic factor (BDNF) in mice with infectious colitis. Using a model of chemical colitis we test whether the anxiolytic effect of B. long
Autor:
Aoife Quinlan, John MacSharry, Peter G. McLean, Andrea C. Haynes, Gerard M. Moloney, Kenneth Nally, Fergus Shanahan, Kevin Lee, Silvia Melgar, Carola T. Murphy, Emilie Faivre, Liam O'Mahony
Publikováno v:
Journal of Leukocyte Biology. 88:1271-1278
Method for in vivo bioluminescence imaging as a valuable strategy for pre-clinical evaluation of leukocyte trafficking as shown here for small molecule α4-integrin antagonists as a promising therapeutic for IBD. Leukocyte trafficking is a therapeuti
Publikováno v:
European Journal of Pharmacology. 589:260-263
Identification of novel drug molecules requires the extensive evaluation in vitro and in vivo. Following in vitro evaluation it is necessary to efficiently screen numerous novel molecules in vivo using relatively simple methodology that requires smal
Autor:
Muriel H. Larauche, Yvette Taché, James A. McRoberts, Peter G. McLean, Emeran A. Mayer, Mulugeta Million, Sylvie Bradesi
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 294:G1033-G1040
Visceral hypersensitivity has been implicated as an important pathophysiological mechanism in functional gastrointestinal disorders. In this study, we investigated whether the sustained visceral hyperalgesia induced by repeated psychological stress i
Autor:
Peter G. McLean, Lijun Lao, Kevin Lee, Emeran A. Mayer, Wendy J. Winchester, Sylvie Bradesi, Gareth A. Hicks
Publikováno v:
Pain. 130:56-65
Despite its beneficial effect in IBS patients, the mechanism of action of the 5-HT3 receptor (5-HT3R) antagonist alosetron is still incompletely understood. We aimed to characterize the effect and site(s) of action in a model of stress-induced sensit
Publikováno v:
Trends in Neurosciences. 30:9-13
In recent times, the perception of functional gastrointestinal disorders such as irritable bowel syndrome (IBS) has shifted fundamentally. Such disorders are now thought of as serious diseases characterized by perturbations in the neuronal regulation
Publikováno v:
Pain. 126:54-63
Conflicting results exist regarding the role of 5-HT3 receptors in somatic and visceral nociceptive processing. We aimed to investigate the effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia. Two